{{Rsnum
|rsid=4668338
|Chromosome=2
|position=170876715
|Orientation=plus
|GMAF=0.1414
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 51.7 | 40.8 | 7.5
| ASW | 66.7 | 21.1 | 12.3
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 52.8 | 39.8 | 7.4
| MEX | 89.7 | 10.3 | 0.0
| MKK | 46.2 | 47.4 | 6.4
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs4668338
|PubMedID=18759275
|Condition=Serum uric acid
|Gene=NR
|Risk Allele=
|pValue=3.00E-006
|OR=4.29
|95CI=NR) mg/dl decrease in uric acid level
|OA=1
}}

{{PharmGKB
|RSID=rs4668338
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:18759275; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in old order amish (Initial Sample Size: 408 women, 460 men; Replication Sample Size: NR). This variant is associated with Serum uric acid levels.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356400
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs4668338
|overall_frequency_n=110
|overall_frequency_d=128
|overall_frequency=0.859375
|n_genomes=51
|n_genomes_annotated=0
|n_haplomes=92
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}